MIGUN LIFE CO., LTD

Migun Life Co., Ltd. specializes in three primary categories of medical devices: non-wearable musculoskeletal infrared phototherapy units, freestanding electric massagers, and line-powered traction tables. These devices are designed for therapeutic purposes, such as pain relief, muscle relaxation, and spinal decompression, and are intended for use in both clinical and home environments. The company’s focus is on delivering solutions for musculoskeletal conditions through these distinct modalities.

Migun Life Co., Ltd. is based in the United States, which means its devices must comply with U.S. medical device regulations, including those enforced by the FDA. Since the company’s products fall under Class I and Class II classifications, they are subject to varying levels of regulatory oversight depending on their risk profile. The U.S. jurisdiction also influences how the devices are listed in registries like the FDA’s Unique Device Identification (UDI) database, ensuring traceability and transparency in the supply chain.

Migun Life Co., Ltd.’s devices are listed in the FDA’s Unique Device Identification (UDI) database. This registry is critical because it provides a standardized way to track and identify medical devices throughout their lifecycle, from manufacturing to patient use. Listing in the UDI system ensures compliance with FDA requirements for device traceability, helps healthcare providers verify product authenticity, and supports post-market surveillance efforts by regulators.

Migun Life Co., Ltd.’s devices are classified as either Class I or Class II under regulatory standards. Class I devices generally pose minimal risk and may require general controls like good manufacturing practices, while Class II devices involve a higher level of risk and may require additional performance standards or post-market surveillance. The classification determines the regulatory pathway for authorization, with Class II devices typically requiring pre-market notifications or clearances to demonstrate safety and effectiveness before commercial distribution.